SUN PHARMACEUTICAL INDUSTRIES (SUNPHARMA)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 5,948.22 4,466.07 5,096.21 5,073.75 5,639.14 4,498.07 5,127.71 6,191.81 7,185.74 5,601.96 4,548.11 5,687.77
YOY Revenue Growth % 57.75% 11.46% -3.58% 9.21% -5.2% 0.72% 0.62% 22.04% 27.43% 24.54% -11.3% -8.14%
Other Income 120.30 163.54 106.54 76.80 118.88 82.74 86.30 68.39 132.00 103.69 72.79 179.90
Total Income 6,068.52 4,629.61 5,202.75 5,150.55 5,758.02 4,580.81 5,214.01 6,260.20 7,317.74 5,705.65 4,620.90 5,867.67
Total Expenses + 3,457.85 3,275.79 3,392.54 3,358.42 3,486.08 3,486.27 3,571.86 3,989.57 4,705.66 4,233.13 3,949.15 4,511.87
Cost of Materials Consumed 1,189.86 1,184.97 1,066.90 1,121.64 1,055.87 973.23 1,225.01 1,162.73 1,329.70 1,067.24 996.19 1,160.49
Employee Benefit Expense 529.05 607.44 600.41 590.13 575.97 645.48 662.19 651.68 648.91 715.00 728.77 739.62
Other Expenses 1,738.94 1,483.38 1,725.23 1,646.65 1,854.24 1,867.56 1,684.66 2,175.16 1,894.04 1,504.40 1,285.99 1,684.75
Operating Profit 2,490.37 1,190.28 1,703.67 1,715.33 2,153.06 1,011.80 1,555.85 2,202.24 2,480.08 1,368.83 598.96 1,175.90
OPM % 41.9% 26.7% 33.4% 33.8% 38.2% 22.5% 30.3% 35.6% 34.5% 24.4% 13.2% 20.7%
Profit Before Tax + -1,030.27 389.88 906.52 751.47 1,401.78 257.92 895.64 1,264.93 2,612.08 1,184.88 671.75 1,097.10
Tax Expense -9.45 9.24 17.89 30.16 534.18 20.10 32.35 83.88 611.62 431.35 107.53 391.66
Tax % - 2.4% 2% 4% 38.1% 7.8% 3.6% 6.6% 23.4% 36.4% 16% 35.7%
Profit After Tax -1,020.82 380.64 888.63 721.31 867.60 237.82 863.29 1,181.05 2,000.46 753.53 564.22 705.44
EPS (Basic) -4.30 1.60 3.70 3.00 3.60 1.00 3.60 4.90 8.30 3.10 2.40 2.90

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Revenue from Operations 23,003.33 20,275.17 20,812.14 15,585.98 12,803.21 12,531.93 10,303.21
YOY Revenue Growth % 13.46% -2.58% 33.53% 21.73% 2.16% 21.63% -
Other Income 369.43 465.76 279.03 957.92 150.22 1,510.92 1,271.44
Total Income 23,372.76 20,740.93 21,091.17 16,543.90 12,953.43 14,042.85 11,574.65
Total Expenses + 18,342.19 13,512.83 13,450.75 11,613.04 8,882.42 8,454.27 7,601.40
Cost of Materials Consumed 4,690.67 4,429.38 5,165.63 4,584.97 3,809.11 3,201.71 2,727.71
Employee Benefit Expense 2,608.26 2,373.95 2,156.95 2,000.78 1,798.45 1,702.77 1,571.34
Other Expenses 7,621.42 6,709.50 6,128.17 5,027.29 3,274.86 3,549.79 3,302.35
Operating Profit 4,661.14 6,762.34 7,361.39 3,972.94 3,920.79 4,077.66 2,701.81
OPM % 20.3% 33.4% 35.4% 25.5% 30.6% 32.5% 26.2%
Profit Before Exceptional 5,030.57 3,668.67 4,678.84 2,127.39 2,242.43 3,253.00 1,933.83
Exceptional Items 0.00 -219.02 -2,937.79 -1,820.53 -89.56 0.00 -1,214.38
Profit Before Tax + 5,030.57 3,449.65 1,741.05 306.86 2,152.87 3,253.00 719.45
Tax Expense 747.95 591.47 50.33 406.85 13.17 41.86 -97.15
Tax % 14.9% 17.1% 2.9% 132.6% 0.6% 1.3% -13.5%
Profit After Tax 4,282.62 2,858.18 1,690.72 -99.99 2,139.70 3,211.14 816.60
EPS (Basic) 17.80 11.90 7.00 -0.40 8.92 13.38 3.40

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
ASSETS
Non-Current Assets + 24,521.06 26,110.38 24,522.34 0.00 0.00 0.00 0.00
Property, Plant & Equipment 4,345.05 4,539.14 4,733.25 0.00 0.00 0.00 0.00
Capital Work in Progress 563.39 388.24 328.87 0.00 0.00 0.00 0.00
Non-Current Investments 12,410.11 12,429.97 12,416.14 0.00 0.00 0.00 0.00
Goodwill 120.80 120.80 120.80 0.00 0.00 0.00 0.00
Other Intangible Assets 2,522.67 3,076.80 3,857.62 0.00 0.00 0.00 0.00
Current Assets + 18,721.98 14,912.54 16,443.75 0.00 0.00 0.00 0.00
Inventories 3,787.49 3,423.62 3,989.19 0.00 0.00 0.00 0.00
Trade Receivables 11,701.43 8,834.16 7,125.02 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 492.02 326.46 410.28 0.00 0.00 0.00 0.00
Current Investments 0.00 0.00 200.26 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 239.93 239.93 239.93 0.00 0.00 0.00 0.00
Other Equity 24,099.92 23,454.47 23,508.43 0.00 0.00 0.00 0.00
Non-Current Liabilities 785.07 12,925.25 8,873.07 0.00 0.00 0.00 0.00
Current Liabilities 18,148.53 4,444.51 8,365.44 0.00 0.00 0.00 0.00
Total Liabilities 18,933.60 17,370.39 17,239.13 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Cash from Operating Activities 4,198.77 -292.42 507.08 7,636.36 0.00 0.00 0.00
Cash from Investing Activities -209.56 -262.91 -705.17 -2,702.10 0.00 0.00 0.00
Cash from Financing Activities -3,831.18 473.95 169.31 -4,870.85 0.00 0.00 0.00
Net Increase/Decrease in Cash 165.56 -83.82 -9.25 68.47 0.00 0.00 0.00